Does RISPERIDONE Cause Product packaging quantity issue? 76 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 76 reports of Product packaging quantity issue have been filed in association with RISPERIDONE (Risperidone). This represents 0.1% of all adverse event reports for RISPERIDONE.
76
Reports of Product packaging quantity issue with RISPERIDONE
0.1%
of all RISPERIDONE reports
0
Deaths
2
Hospitalizations
How Dangerous Is Product packaging quantity issue From RISPERIDONE?
Of the 76 reports, 2 (2.6%) required hospitalization.
Is Product packaging quantity issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISPERIDONE. However, 76 reports have been filed with the FAERS database.
What Other Side Effects Does RISPERIDONE Cause?
Gynaecomastia (24,453)
Off label use (10,376)
Abnormal weight gain (9,418)
Weight increased (6,885)
Emotional disorder (5,809)
Product use in unapproved indication (5,551)
Drug ineffective (5,232)
Injury (4,447)
Hyperprolactinaemia (4,124)
Galactorrhoea (3,513)
What Other Drugs Cause Product packaging quantity issue?
LEUPROLIDE (523)
ALBUTEROL (431)
BUDESONIDE\FORMOTEROL (301)
FENTANYL (286)
BUPRENORPHINE (225)
CYCLOSPORINE (206)
ESTRADIOL (201)
BIMATOPROST (177)
RIVAROXABAN (174)
EXENATIDE (154)
Which RISPERIDONE Alternatives Have Lower Product packaging quantity issue Risk?
RISPERIDONE vs RITALIN
RISPERIDONE vs RITLECITINIB
RISPERIDONE vs RITODRINE
RISPERIDONE vs RITONAVIR
RISPERIDONE vs RITUXAN